Skip to main content
Clinical Trials/ChiCTR2300068774
ChiCTR2300068774Not yet recruitingPhase 1

右美托咪定联合癫狂梦醒汤穴位贴在老年患者术后谵妄随机临床研究

甘肃省中医药管理局项目资助1 site in 1 countryStarted: October 31, 2022Last updated:

Trial Snapshot

Phase
Phase 1
Status
Not yet recruiting
Sponsor
Locations
1
Primary Endpoint
是否谵妄

Study Overview

Brief Summary

1.明确癫狂梦醒汤治疗重症谵妄的作用及分子机制; 2.制备癫狂梦醒汤穴位贴; 3.揭示右美托咪定联合癫狂梦醒穴位贴治疗老年大手术患者术后谵妄的临床疗效。

Study Design

Study Type
干预性研究
Primary Purpose
随机平行对照
Masking

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 2.术前未发生谵妄患者;
  • 3.术前均无长期服用镇静药物史;
  • 4.具有完整病例并按时到院复查;
  • 5.经医院伦理委员会批准,患者及家属均签署知情同意书。

Exclusion Criteria

  • Not provided

Arms & Interventions

常规+右美托咪定干预组

常规+右美托咪定联合癫狂梦醒穴位贴干预组

常规治疗组

Outcomes

Primary Outcomes

是否谵妄

Time Frame: 早晚

Secondary Outcomes

  • 疼痛程度(早晚)
  • 睡眠质量(早上)
  • 精神状态
  • 记忆能力

Investigators

Sponsor
甘肃省中医药管理局项目资助

Study Sites (1)

Loading locations...

Similar Trials